Salarius Pharmaceuticals
SLRX
SLRX
24 hedge funds and large institutions have $859K invested in Salarius Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
41% less capital invested
Capital invested by funds: $1.45M → $859K (-$591K)
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$99.7K | |
| 2 | +$56.6K | |
| 3 | +$35K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$14.4K |
| 5 |
VF
Virtu Financial
New York
|
+$8.81K |
Top Sellers
| 1 | -$218K | |
| 2 | -$45K | |
| 3 | -$7K | |
| 4 |
Two Sigma Advisers
New York
|
-$5.7K |
| 5 |
Jane Street
New York
|
-$4K |